Effects of oral administration of Bifidobacterium animalis subsp. lactis HN019 on the treatment of plaque-induced generalized gingivitis.

OBJECTIVES: This double-blind, randomized, placebo-controlled clinical trial evaluated the adjuvant effects of Bifidobacterium lactis HN019 on the treatment of plaque-induced generalized gingivitis. MATERIALS AND METHODS: Sixty patients were submitted to professional supragingival scaling and prophylaxis. They were randomly assigned to test (probiotic lozenges containing B. lactis HN019, n = 30) or control (placebo lozenges, n = 30) groups. Lozenges were consumed twice a day for 8 weeks. Bleeding on probing (BoP), Gingival Index (GI), Plaque Index (PI), probing depth (PD), and clinical attachment level (CAL) were evaluated at baseline and after 2 and 8 weeks. Gingival crevicular fluid (GCF) was collected at baseline and at 8 weeks for analysis of the inflammatory mediators IL-1ß, IL-1α, IL-8, MCP-1, and MIP-1ß. Data were statistically analyzed (p < 0.05). RESULTS: After 8 weeks, both groups showed reduction in the percentage of PI, with no significant difference between groups (p = 0.7423). The test group presented a lower percentage of BoP and a higher percentage of sites with GI ≤ 1 when compared with the control group at the end of the study (p < 0.0001). At 8 weeks, the test group had a greater number of patients without generalized gingivitis than the control group (20 and 11 patients, respectively; p < 0.05). The test group presented significantly lower levels of IL-1α, IL-1ß, and MCP-1 in GCF than the control group at the end of the study (p < 0.05). CONCLUSION: The adjunct use of B. lactis HN019 promotes additional clinical and immunological benefits in the treatment of generalized gingivitis. CLINICAL RELEVANCE: B. lactis HN019 can be an efficient and side-effect-free adjunct strategy in the treatment of generalized gingivitis.

Alterations in masticatory cycle efficiency and bite force in individuals with periodontitis.

OBJECTIVES: The objective of this research was to evaluate the effect of periodontitis on masticatory cycle efficiency and maximum molar bite force. METHODS: Twenty-four individuals were divided into two groups: With periodontitis (Group I; mean age ± standard deviation (SD), 51.3 ± 2.8 years; n = 12) and without periodontitis (Group II; mean age ± SD, 48.9 ± 2.4 years; n = 12). Masticatory cycle efficiency was obtained from the value of the ensemble-averaged integrated linear envelope electromyographic signal of the masseter and temporalis muscles. Maximum bite force was recorded for the right and left molar regions. The data were tabulated and submitted to statistical analysis (P ≤ 0.05). RESULTS: There was a significant difference between the groups for the left masseter muscle when chewing raisins (P = 0.04), peanuts (P = 0.02), and biocapsules (P = 0.01). Multiple regression analysis demonstrated the influence of dental mobility on masticatory cycle efficiency for peanuts (P = 0.03) and biocapsules (P = 0.01). The maximum bite force for the left molar region was significantly different between the groups (P = 0.02). Dental mobility was a variable that had a greater effect on masticatory cycle efficiency. The periodontitis group had a reduced bite force. CONCLUSION: The present study findings indicate that the loss of periodontal supporting structures had a negative impact on masticatory cycle efficiency and molar bite force. This finding suggested that dental mobility should be considered when determining clinical treatments aimed at improving masticatory efficiency and bite force in individuals with the periodontal disease.